Cite Filings / LIMN
Feed Companies Filings Check
Sign in

CIK 0001971387 · <br>Emerging growth company

Liminatus Pharma, Inc.

Sign in to watch
Ticker
LIMN
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
213-273-5453
Business address
12611 HIDDENCREEK WAY, UNIT C, CERRITOS, CA, 90703
Former names
Iris Parent Holding Corp.

Securities

  • LIMN Class A Common Stock Nasdaq
  • LIMNW Warrants Nasdaq
Filings Insiders Search text
All 109 Financials 31 Shareholder Meetings 2 Executive Compensation 27 Insider Trading 16 Beneficial Ownership Interest 11 Business Combinations 31 Public Offerings 31 Mutual Funds and ETFs 1 Others 13
›
Filed in
  1. No filings match these filters. Clear filters
  2. CORRESP Other Correspondence Between Filers and SEC Staff 2024-07-25
  3. UPLOAD Other SEC-generated Letter 2024-07-11
  4. S-4/A Deal Registration Statement - Business Combination 2024-06-14
  5. CORRESP Other Correspondence Between Filers and SEC Staff 2024-06-14
  6. UPLOAD Other SEC-generated Letter 2023-12-04
  7. CORRESP Other Correspondence Between Filers and SEC Staff 2023-11-08
  8. S-4 Deal Registration Statement - Business Combination 2023-11-08
  9. UPLOAD Other SEC-generated Letter 2023-05-30
  10. DRS Other Draft Registration Statement 2023-05-02

Page 6 of 6 · 109 filings

First Previous Next Last

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…